Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Non-Exec Chairman Appointment

5 Sep 2007 07:01

BrainJuicer Group PLC05 September 2007 Press Release 5 September 2007 BrainJuicer Group PLC ("BrainJuicer" or "the Company") Appointment of Ken Ford as non-executive Chairman BrainJuicer Group PLC, (AIM: BJU), a leading international online marketresearch agency, today announced that it has appointed Eric Kenelm Ford, (KenFord), 58, as non-executive Chairman, with immediate effect. The Board'sdecision to split the roles of Chairman and CEO is in line with best practice,and will further strengthen the Company's governance. Ken was previously Chief Executive of Teather & Greenwood the investment bank,becoming Deputy Chairman and Chairman of Corporate Finance in 2004, and brings36 years City experience to the Company, including a strong understanding ofshareholder value, strategic planning and corporate transactions. Ken wasChairman of the UK Society of Investment Analysts between 1985 - 1987, Chairmanof the Quoted Company's Alliance (QCA) in 2003-2004 and is a former member ofthe EU Advisory Committee to the Corporation of London. Ken's previousdirectorships include Aberdeen Asset Management, Morgan Grenfell and WeddDurlacher. John Kearon, CEO of BrainJuicer, commented: "We are delighted that Ken hasagreed to join the Company, and the Board welcomes his insight and guidance. Thesplitting of the roles of Chairman and CEO further strengthens the Board'sgovernance, and we are pleased to have someone with Ken's reputation andexperience." Ken Ford, non-executive Chairman of BrainJuicer, commented: "BrainJuicer is anexciting Company with considerable prospects for growth, and I am lookingforward to working with the Board to realise the Company's potential. TheCompany's innovative approach to its market puts it in a strong position, and Iam keen to work alongside the team to further grow the business." Current DirectorshipsBrainJuicer Group PLCThe Wells Fine Dining Company LimitedMintonview LimitedTeather & Greenwood Holdings PLCTeather & Greenwood Nominees LimitedTeawood Nominees LimitedLandsbanki Securities (UK) LimitedCamomile Wood Nominees LimitedEscalon Investments Limited Past directorships held in last 5 yearsFirst Manchester Properties LimitedCounty of Kent Developments LimitedNationwide Residential Properties LimitedThe Quoted Companies Alliance Other Disclosable InformationBy Board Notice 431 dated 16 July 1997 the Securities and Futures Authority("SFA") gave notice that disciplinary proceedings brought against Teather &Greenwood Limited Partnership (of which Mr Ford was a partner) and Mr Fordrelating to breaches of the Securities and Investment Board Principles 2 and 9had been concluded by Settlement with the following outcome: a) Teather & Greenwood Limited Partnership was reprimanded, fined £50,000and agreed to pay a contribution of £10,000 towards SFA's costs; and b) Mr Ford was reprimanded, fined £8,000 and agreed to pay a contributionof £2,000 towards SFA's costs. SFA took into account that Teather & Greenwood Limited Partnership hadpreviously conducted a full internal review of its compliance procedures and hadimplemented a remedial action plan. SFA also took into account that neitherTeather & Greenwood Partnership nor Mr Ford has previously been the subject ofdisciplinary action, both cooperated with SFA and no clients had beendisadvantaged. Mr Ford was also reprimanded by the Securities Institute as aresult. There are no further disclosures to be made regarding this appointment underSchedule 2 paragraph (g) of the AIM rules. - Ends - For further information, please contact:BrainJuicer plcJohn Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000 www.brainjuicer.com Landsbanki Securities (UK) LimitedFred Walsh / Simon Brown Tel: +44 (0)20 7426 9000 www.landsbanki.co.uk Media enquiries:Abchurch CommunicationsHeather Salmond / Joanne Shears Tel: +44 (0) 20 7398 7700joanne.shears@abchurch-group.com www.abchurch-group.com Notes to Editors: BrainJuicer carries out quantitative online research using innovative, bespokesoftware to produce insightful market research for large, multinationalcompanies, including 10 of the world's top 50 companies (FT 500 September 2006). BrainJuicer operates in a growing sector of the US$25bn global research market,namely quantitative online research. BrainJuicer's main competitors are largetraditional market research providers who have dominated the market for off-linemarket research, such as AC Nielsen, Millward Brown, Research International andTaylor Nelson Sofres. Whilst the largest traditional research companies have developed their ownonline capability, BrainJuicer has a number of key attributes which havecontributed to it achieving rapid growth and winning contracts with prestigiousclients, including: • Research platform that delivers greater diagnostic insight. BrainJuicer hasdeveloped tools and award-winning techniques that enable it to provide a greaterlevel of diagnostic insight into quantitative market research. These techniquesenable clients to enhance their understanding of consumer preference and helpthem make decisions on the best way to develop their products and services. • Speed. BrainJuicer's automated research techniques enable it to conductcomplicated studies very quickly. BrainJuicer's rapid deployment and resultsproduction, even on multi-country studies, provide clients with a speed tomarket advantage in the development of new products and services. • A scaleable online-only business model. Unlike the traditional researchcompanies who maintain both on and offline data collection capabilities,BrainJuicer is able to focus on operating a scaleable online-only businessmodel. To date the Group has conducted projects in over 50 countries and more than 30languages and has established offices in the UK, the Netherlands and the US. The Group's revenues come from full service market research work, and from itsonline Juicy Brains Panel in the UK. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.